Humana Inc. (NYSE:HUM)’s share price hit a new 52-week low during trading on Tuesday . The stock traded as low as $150.00 and last traded at $150.30, with a volume of 5,973,778 shares trading hands. The stock had previously closed at $159.64.

Several equities analysts recently commented on HUM shares. JPMorgan Chase & Co. cut shares of Humana from an “overweight” rating to a “neutral” rating and reduced their price objective for the company from $196.00 to $150.00 in a research note on Friday, July 8th. Zacks Investment Research lowered shares of Humana from a “hold” rating to a “sell” rating in a research report on Tuesday, April 12th. Leerink Swann reiterated an “outperform” rating on shares of Humana in a research report on Tuesday, April 5th. Credit Suisse Group AG reiterated a “hold” rating on shares of Humana in a research report on Tuesday, June 28th. Finally, Jefferies Group upgraded shares of Humana from a “hold” rating to a “buy” rating and lifted their target price for the company from $158.89 to $210.00 in a research report on Monday. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and five have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of $206.36.

The firm has a market capitalization of $23.61 billion and a PE ratio of 22.08. The firm has a 50 day moving average price of $177.05 and a 200 day moving average price of $174.38.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, May 4th. The insurance provider reported $1.86 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.81 by $0.05. The business earned $13.80 billion during the quarter, compared to the consensus estimate of $13.80 billion. Humana’s revenue for the quarter was down .2% on a year-over-year basis. During the same quarter last year, the company earned $2.58 EPS. Equities research analysts predict that Humana Inc. will post $8.87 earnings per share for the current year.

Several institutional investors have modified their holdings of HUM. Tredje AP fonden boosted its position in shares of Humana by 1.7% in the fourth quarter. Tredje AP fonden now owns 9,477 shares of the insurance provider’s stock valued at $1,694,000 after buying an additional 158 shares during the period. Gamco Investors INC. ET AL raised its stake in Humana by 12.1% in the fourth quarter. Gamco Investors INC. ET AL now owns 9,620 shares of the insurance provider’s stock valued at $1,717,000 after buying an additional 1,040 shares in the last quarter. Deere & Co. raised its stake in Humana by 791.1% in the fourth quarter. Deere & Co. now owns 10,078 shares of the insurance provider’s stock valued at $1,799,000 after buying an additional 8,947 shares in the last quarter. Suntrust Banks Inc. raised its stake in Humana by 600.1% in the fourth quarter. Suntrust Banks Inc. now owns 10,264 shares of the insurance provider’s stock valued at $1,831,000 after buying an additional 8,798 shares in the last quarter. Finally, GSA Capital Partners LLP raised its stake in Humana by 5.1% in the fourth quarter. GSA Capital Partners LLP now owns 11,343 shares of the insurance provider’s stock valued at $2,025,000 after buying an additional 554 shares in the last quarter.

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.